We use essential cookies. With your permission, providers such as Google and Meta can learn you visited ProtocolHRT and use that information for analytics and advertising.

Full cookie notice

ProtocolHRT is a telehealth brand for hormone, weight and wellness programs. We use cookies that are needed to run this website. With your permission, we also use analytics and advertising cookies and pixels from providers such as Google and Meta on our general pages. If you accept, those providers will learn that your browser visited ProtocolHRT and may use that to show and measure our ads. They never run on health, questionnaire, checkout or account pages, and we never share your questionnaire answers with advertisers. You can change your choice at any time in Cookie Settings.

Privacy Statement | California Privacy Disclosures (Notice at Collection) | Cookie List

Medical group document · LocumTele

Telehealth Informed Consent

The medical group's telehealth informed consent for care through protocolhrt.com.

Issued by Joseph M. Palumbo, D.O., P.A.; Joseph M. Palumbo, D.O. - East, P.C.; and Joseph M. Palumbo, D.O. - West, P.C. (together, “LocumTele”)

Effective Date: October 12, 2026 Last Updated: October 12, 2026 Version: 1.0

1. Purpose of This Consent and the Parties

1.1 This Consent. This Telehealth Informed Consent (this “Consent”) explains what telehealth is, its potential benefits, risks and limitations, the alternatives, and your rights, so that you can make an informed decision about receiving care through telehealth. This Consent is between you and LocumTele, an independent medical group (the “Medical Group”), and the licensed clinicians who provide care through the Medical Group (each, a “Provider”).

1.2 Your Provider. Your Provider may be a physician, nurse practitioner or physician assistant who is licensed in the state where you are located at the time of your visit and who is affiliated with the Medical Group. Your Provider’s name, professional title, license number and states of licensure will be available to you in the patient portal before or at your visit and at any time on request. Your treating Provider may be a nurse practitioner or physician assistant rather than a physician, practicing within the scope and any supervision or collaboration the law of your state requires. Where the law of your state gives you the right to be seen by a physician, you may ask for one and the Medical Group will arrange it. You may verify any Provider’s license with the licensing board in your state.

1.3 Adults only. You must be at least eighteen (18) years old. The Medical Group’s telehealth services are available only to adults who are consenting for themselves. By accepting this Consent, you confirm that you are at least eighteen (18) and that you are the person who will receive care.

1.4 Who does what. ProtocolHRT, LLC (“ProtocolHRT”) owns and operates the ProtocolHRT brand and online storefront, and it is also the Medical Group’s management services organization and business associate. In both roles it provides only non-clinical services: the website, the Pre-Visit Questionnaire, the Protocol Guide, account and membership administration, scheduling and customer support, billing and collection as the Medical Group’s collection agent, coordination of pharmacy and laboratory logistics, and administrative, technology and business support to the Medical Group under a written management services agreement. ProtocolHRT has no authority over clinical decisions; the Medical Group alone controls all clinical matters, its Providers and your medical records. ProtocolHRT is not a medical practice or a pharmacy. It does not practice medicine or pharmacy, does not employ or direct clinicians, does not decide who is eligible for treatment, and does not prescribe, compound, label or dispense medication. ProtocolHRT is not a party to your provider-patient relationship and does not influence any clinical decision. ProtocolHRT presents this Consent and records your electronic signature on the Medical Group’s behalf as a non-clinical administrative task. All health care services are provided solely by the Medical Group and your Provider. If your Provider prescribes a medication, the prescription is sent to an independently owned, state-licensed pharmacy (the “Dispensing Pharmacy”), which provides its pharmacy services under its own license and professional responsibility.

1.5 The Medical Group’s own document. This Consent is the Medical Group’s own document. The ProtocolHRT Terms of Service refer to it, but it is not part of those Terms, and nothing in those Terms changes it.

2. What Telehealth Is

2.1 Telehealth. Telehealth is the delivery of health care services using electronic communications when you and your Provider are not in the same place. Depending on the state where you are located, your condition and your Provider’s judgment, your care may involve: live video visits; telephone visits; asynchronous (store-and-forward) review, in which your Provider reviews your health questionnaire, history, photographs, records and test results and responds without a real-time conversation; secure messaging with your Provider or care team through the patient portal; electronic transmission of records and images; and ongoing management of your treatment, including prescribing where clinically appropriate and permitted by law.

2.2 How an asynchronous evaluation works. You complete a health questionnaire and upload anything your Provider needs, such as recent lab results or a medication list. Your Provider reviews everything you send and your available prescription history, may message you with follow-up questions, and then decides whether a treatment is appropriate, whether a live visit is needed first, or whether you should be seen in person. Your questionnaire is information for your Provider; it is never the evaluation by itself.

2.3 Synchronous and asynchronous care. By accepting this Consent, you expressly consent to receiving care through synchronous modalities (real-time audio or audio-video) and asynchronous modalities (review of your information without a real-time interaction), as your Provider determines is clinically appropriate and as permitted by the law of the state where you are located. If that state requires a synchronous interaction before a provider-patient relationship is established or before a medication is prescribed, the Medical Group will require that interaction before any prescribing decision. You may ask for a live video visit at any time, and the Medical Group will provide one where it is available for your care program and permitted in your state.

2.4 Testosterone and other controlled substances. Testosterone is a Schedule III controlled substance. Before a first prescription for testosterone or any other controlled substance, your Provider will conduct a live, real-time video visit with you, and an in-person visit where the law of your state requires it. Federal telemedicine flexibilities issued by the U.S. Drug Enforcement Administration and the U.S. Department of Health and Human Services currently allow a controlled substance to be prescribed through telemedicine without a prior in-person visit through December 31, 2026. If those flexibilities end or change, you may be required to have an in-person evaluation, or to see a Provider who meets new federal requirements, before a new or continued prescription can be issued, and the Medical Group will tell you what is needed. Before prescribing or renewing a controlled substance, your Provider will check your state’s prescription drug monitoring program where the law requires it. Your Provider will also require regular laboratory monitoring and may require you to sign the Medical Group’s Controlled Substance Treatment Agreement.

2.5 Your location. Your Provider must be licensed or otherwise authorized to practice in the state where you are physically located at the time of each visit, so you will be asked to confirm your location at each encounter.

3. Potential Benefits

3.1 Benefits. Telehealth can improve access to care by allowing you to be evaluated and treated without traveling to an office, at times that may be more convenient for you, and from a private place you choose. It can make follow-up care, monitoring and communication with your Provider more efficient. These benefits are possible, not guaranteed, and telehealth may not be the right way to receive care for every condition.

4. Potential Risks and Limitations

4.1 Risks. As with any health care service, telehealth has risks and limitations, including that:

  • (a) your Provider cannot perform a hands-on physical examination, and in some cases your Provider may not have enough information to make a clinical judgment, because of technology limits or the information provided;
  • (b) failures of equipment, software or internet connections may delay or interrupt your care, and a visit may need to be rescheduled or completed another way;
  • (c) in rare cases, security protections could fail and the privacy of your health information could be compromised despite reasonable safeguards;
  • (d) incomplete or inaccurate information could lead to drug interactions, allergic reactions or other errors, which is why you must give complete and accurate information, including all medications, supplements, allergies and conditions;
  • (e) state law may limit what can be diagnosed or prescribed through telehealth, and your Provider may decide that telehealth is not appropriate for you, in which case you will be advised to seek in-person care and no treatment or prescription will be provided through telehealth;
  • (f) messages are not answered in real time, and a response to a non-urgent message may take up to one (1) business day;
  • (g) shipping, pharmacy processing or state rules may delay when you receive a prescribed medication; and
  • (h) telehealth is not appropriate for emergencies (see Section 10).

5. Alternatives, Voluntary Participation and Your Rights

5.1 Alternatives. Alternatives to telehealth are available at any time, including in-person evaluation and treatment by a clinician of your choosing, other treatments your Provider may discuss with you, and no treatment. The Providers who practice through this telehealth service do not offer in-person visits; the Medical Group can give you a referral. Your participation is voluntary. You have the right to:

  • withhold or withdraw this Consent at any time without affecting your right to future care or treatment elsewhere;
  • ask questions about telehealth, your treatment and its alternatives, risks and benefits, and have them answered before you proceed;
  • request a referral for in-person care or seek care elsewhere at any time;
  • access and get copies of your medical records as the law provides;
  • ask to communicate with a human Provider at any time, including about any information generated by artificial intelligence; and
  • receive reasonable accommodations and free language assistance services, including qualified interpreters, translated materials, captioning and screen-reader compatible documents.

5.2 How to withdraw. Your withdrawal takes effect when the Medical Group receives it through the patient portal or in writing at LocumTele, 5247 Wilson Mills Rd., #707, Richmond Heights, OH 44143. You may also call 1-888-219-2204, and your request will be passed to the Medical Group and recorded. Withdrawal does not affect actions taken in reliance on this Consent before then, and it may mean that services can no longer be provided to you through telehealth. If you are taking a prescribed medication, talk with a clinician before stopping it, because some medications, including testosterone, should not be stopped without guidance.

6. No Guarantee of Treatment, Prescription or Outcome

6.1 Independent clinical judgment. Creating an account, using the Pre-Visit Questionnaire, completing a health assessment, enrolling in a membership or paying any amount does not guarantee that you will receive a prescription. All treatment and prescribing decisions are made solely by your Provider in the exercise of independent professional judgment, based on your individual clinical presentation, history and applicable standards of care, and only where your Provider determines that a valid provider-patient relationship exists and treatment is medically appropriate. Your Provider may prescribe a different medication, dose or form than the one you selected, or none at all. If your Provider recommends a treatment with a different price, you will be asked to approve it separately before you are charged. No specific result can be promised; your condition may not improve and in some cases may worsen.

7. Compounded Medications

7.1 Compounded medication acknowledgment. Some medications your Provider may prescribe, including tirzepatide, oral testosterone, sermorelin, NAD+, glutathione and oxytocin, are compounded. If your Provider prescribes a compounded medication, you acknowledge that:

  • compounded medications are prepared by a state-licensed pharmacy for an individual patient based on a prescription from a licensed provider;
  • compounded medications are not FDA-approved, and the FDA does not review compounded medications for safety, effectiveness or quality before they are dispensed;
  • a compounded medication is not a generic version of, the same as, or interchangeable with any FDA-approved drug, and its strength, purity and stability can vary;
  • where an FDA-approved medication is commercially available, your Provider will prescribe a compounded version only after deciding, for you individually, that a documented, clinically significant difference makes it appropriate for you;
  • some compounded medications are prescribed for uses the FDA has not approved, and your Provider will explain the reasons, potential benefits, risks and alternatives; and
  • FDA-approved options are available for some conditions, and you may ask your Provider about them at any time.

7.2 Treatment-specific consents. Before you begin a specific medication or program, the Medical Group will present a treatment-specific consent for that treatment category, describing its nature, potential benefits, material risks, monitoring, alternatives and your responsibilities, together with the Important Safety Information for that medication. Each treatment-specific consent you accept is part of this Consent.

8. Artificial Intelligence and Your Pre-Visit Report

8.1 The Pre-Visit Report. ProtocolHRT operates the Pre-Visit Questionnaire, a pre-visit intake that collects the health information your Provider needs to facilitate your visit, such as your goals, symptoms, sex at birth, date of birth, height, weight, medications, current treatments and state. It may use artificial intelligence (“AI”) to produce a summary of the answers you gave (a “Pre-Visit Report”). The Pre-Visit Report is not created by the Medical Group or any Provider, is not reviewed by a clinician before you see it, and is not a diagnosis, treatment plan, prescription or recommendation.

8.2 How the Medical Group uses it. The Medical Group receives your Pre-Visit Questionnaire answers and Pre-Visit Report to facilitate your visit, with support from ProtocolHRT as the Medical Group’s management services organization and business associate. Once received, they become part of your medical record under the Medical Group’s Notice of Privacy Practices, and the Pre-Visit Report is labeled as an AI-generated summary of your own answers. Your Provider may read it as background, but will confirm your history, symptoms, medications and goals directly with you, will not rely on it alone, and makes every clinical decision independently. Your Provider may reach conclusions that differ from anything in your Pre-Visit Report.

8.3 Other technology in your care. Your care may involve clinical documentation and decision-support technologies, which may include AI tools used for documentation assistance, summarizing information you provide, checking for drug interactions and quality review. These tools support, and never replace, your Provider’s professional judgment. Your Provider reviews any AI-assisted output, including all AI-generated records, before relying on it or making a clinical decision. You may ask what technologies are used in your care and how your information is processed, and you may ask that such tools not be used in aspects of your care where feasible.

8.4 AI-generated messages. If the Medical Group sends you a message about your health that was generated by AI and was not read and reviewed by a licensed Provider before it was sent, the message will begin with a statement that it was generated by AI and will tell you how to reach a human Provider. The Medical Group’s standard practice is for a licensed Provider or clinical team member to review clinical messages before they are sent.

8.5 Your right to a human Provider. You may ask at any time to communicate with a human Provider instead of, or about, any AI-generated content, through the patient portal or by calling 1-888-219-2204.

8.6 Recording and AI scribes. No visit will be recorded (audio or video), and no ambient documentation technology (an AI “scribe” that listens to a visit to draft notes) will be used, unless you first agree in a separate yes or no consent. You may say no, or ask that recording or the scribe be stopped at any time during a visit, and your care will not be affected. You may not record a visit without your Provider’s consent.

9. Privacy, Medical Records and Communications

9.1 Privacy. The Medical Group is subject to the Health Insurance Portability and Accountability Act (“HIPAA”) and applicable state privacy laws, and the laws that protect the privacy of health information in person also apply to telehealth. The Medical Group maintains your medical record and will give you access to it or copies of it as the law provides. You consent to the Medical Group and your Provider obtaining, importing and reviewing your available medical records and medication history, including prescription history records from pharmacy and electronic prescribing networks, in connection with your care.

9.2 Sharing with service providers. The Medical Group may share your health information with the Dispensing Pharmacy, laboratories and service providers that support your care under business associate agreements that require them to protect it, including ProtocolHRT, as the Medical Group’s management services organization, and the Medical Group’s electronic health record vendor, as needed for treatment, payment and health care operations and as described in the Medical Group’s Notice of Privacy Practices, available at protocolhrt.com/notice-of-privacy-practices and in the patient portal. Your health information will not be sold and will not be used or disclosed for marketing or advertising without your separate written authorization. ProtocolHRT’s optional Marketing Authorization and Advertising Authorization cover only the limited information they describe, collected before your first visit with a provider, never your visit notes, prescriptions, purchases, or any questionnaire answer other than goals you chose before requesting care; each is also designed to serve as your authorization under HIPAA for that limited information, and each is optional and may be revoked at any time.

9.3 Private setting and visit conduct. Please take part in visits from a private, safe location, and not while driving. Your Provider will do the same. If anyone else is present on the Provider’s side, you will be told who they are and why, and you may object. Please join each visit clear-headed, not under the influence of alcohol or of drugs not prescribed to you, and dressed as you would be for an in-person appointment. If a visit cannot be completed safely or appropriately, including because of a poor connection, your Provider may pause, end or reschedule it, and the Medical Group will follow up with you about next steps.

9.4 How the Medical Group communicates. The Medical Group and your care team may contact you through the patient portal, secure messaging, email, text message (where you have agreed to receive texts) and telephone about your care, including visit, evaluation, prescription, refill, laboratory and follow-up messages. Standard email and text messages may not be secure. Use the patient portal for sensitive clinical communications where possible. You may tell the Medical Group at any time how you prefer to be contacted.

10. Emergencies

TELEHEALTH IS NOT FOR EMERGENCIES. IF YOU THINK YOU ARE HAVING A MEDICAL EMERGENCY, CALL 911 OR GO TO THE NEAREST EMERGENCY ROOM NOW. IF YOU ARE HAVING THOUGHTS OF SUICIDE OR ARE IN CRISIS, CALL OR TEXT 988. DO NOT WAIT FOR A RESPONSE THROUGH THE PATIENT PORTAL.

10.1 Reaching your care team. Providers may not respond immediately to messages, and messages are not monitored around the clock. If a technical problem prevents you from reaching your care team about a non-emergency matter, call 1-888-219-2204 or email support@protocolhrt.com, and your message will be passed to the Medical Group. If you have a side effect, contact your Provider through the patient portal or by calling ProtocolHRT support at 1-888-219-2204, which routes clinical questions to the Medical Group’s Providers. You may also report side effects to the FDA at www.fda.gov/medwatch or by calling 1-800-FDA-1088.

10.2 Emergency contact. You agree to keep your physical location and an emergency contact current in your account. If your Provider believes you are having an emergency, your Provider may contact emergency services, your emergency contact, or both.

11. Your Responsibilities

11.1 What you agree to do. You agree to:

  • give complete, accurate and current information about your identity, physical location, health history, symptoms, medications, supplements and allergies, and update it if it changes;
  • confirm your physical location at each visit, because your Provider must be authorized to practice where you are;
  • take part in the follow-up care, monitoring and laboratory testing your Provider recommends, and take medications only as prescribed;
  • report side effects and new symptoms promptly to your Provider;
  • use any medication prescribed to you only for yourself and never share or sell it;
  • keep a relationship with a primary care clinician where possible, tell your other clinicians about the treatment you receive through telehealth, and share relevant results with them;
  • keep your account login private and not let anyone else use your account; and
  • use a private, secure location and device for your visits.

12. Laboratory Services

12.1 Lab testing. If your care includes laboratory testing, your Provider will order tests where clinically appropriate, and some treatments, including testosterone, require testing before and during treatment. Tests may use an at-home collection kit, a home blood draw or an in-person draw at a collection site, and are performed by independent licensed laboratories. You may also provide results from a laboratory you choose if your Provider decides they meet clinical needs. Blood draws can cause discomfort, bruising, swelling, bleeding, lightheadedness and, rarely, infection. No laboratory test is perfectly accurate; results can be false positive, false negative or inconclusive, and a sample may need to be collected again. Where the law allows, you choose to receive your results directly in the patient portal when the report is complete; some states require a delay so your Provider can review results with you first. Your Provider will review your results and contact you about anything that needs follow-up.

13. Fees and Your Freedom of Choice

13.1 Self-pay. The Medical Group’s telehealth services are provided on a self-pay basis, outside Medicare, Medicaid and other government or private insurance programs, and the Medical Group will not submit a claim to any of them for these services. The Medical Group sets its own professional fees. How fees are billed and paid is described in the ProtocolHRT Terms of Service at protocolhrt.com/terms-of-service. Your consent to telehealth care is separate from your agreement to those financial terms. Medication prices are not set by your Provider, and your Provider’s prescribing decisions are independent of cost and of any membership you purchase. As a self-pay patient, you are entitled to a Good Faith Estimate of expected charges from the Medical Group, as described in the Good Faith Estimates section of the Medical Group’s Patient Bill of Rights and Responsibilities at protocolhrt.com/patient-bill-of-rights.

13.2 Relationships. ProtocolHRT is the Medical Group’s management services organization and provides non-clinical administrative, technology, billing and collection, and business support services to the Medical Group under a written management services agreement. That arrangement gives ProtocolHRT no authority over clinical decisions and does not affect, and is not permitted to influence, your Provider’s clinical judgment. The Medical Group’s professional fee never depends on whether a prescription is written or which medication is prescribed, and your Provider is not paid more or less based on either.

13.3 Your freedom of choice. You are free to get your evaluation from any health care provider, to have any prescription filled at any licensed pharmacy of your choice that can fill it, and to use any laboratory you prefer. Your choice of pharmacy or laboratory will not affect your care. To send a prescription to a pharmacy you choose, message your Provider through the patient portal.

14. Continuity of Care

14.1 Transitions. If your Provider becomes unavailable, another qualified Provider will be assigned or you will be given reasonable time to arrange other care. If the Medical Group decides to end your provider-patient relationship, it will give you reasonable notice in writing, help you transition your care, provide a bridge prescription where it is clinically appropriate and lawful, and send your records to you or your new clinician on request. If ProtocolHRT or the technology platform stops operating, the Medical Group remains responsible for your medical records and for helping you transition your care.

15. State-Specific Requirements

15.1 State disclosures. Some states require additional consents, specific language, modality limits, notices or reports. The state-specific disclosures in Appendix A apply if you are located in the listed state and are part of this Consent. Any additional state consent presented to you before or during a visit is also part of this Consent and controls to the extent it imposes additional requirements. Where the law of the state where you are located gives you greater rights or protections than this Consent, that law applies. The Medical Group records your consent to telehealth in your medical record before your first telehealth service and asks you to renew it when the Medical Group publishes a new version or when the law of your state requires.

16. This Consent Does Not Limit Your Rights

16.1 Your rights are preserved. This Consent is intended to help you make an informed decision about your care. Accepting it does not give up any of your legal rights, and it does not limit the Medical Group’s or your Provider’s responsibility for the care they provide.

17. Acknowledgment and Electronic Signature

17.1 Acknowledgment. By checking the acceptance box or signing electronically, you acknowledge and agree that:

  • you are accepting this Consent on behalf of yourself, as the patient;
  • you have read and understand this Consent and each treatment-specific consent presented to you, or have had them explained to you;
  • you have had the opportunity to ask your Provider questions (for an online review, by secure message through the patient portal before your Provider makes a treatment decision; for a live visit, during the visit), you may ask more questions at any time, and any questions you asked have been answered;
  • you understand the potential benefits, risks and limitations of telehealth and of the treatment described in each treatment-specific consent, and the alternatives, including in-person care and no treatment;
  • you understand the compounded medication acknowledgment in Section 7 and the information about artificial intelligence in Section 8;
  • your participation is voluntary and you may withdraw this Consent as described in Section 5;
  • all health care services are provided by the Medical Group and your Provider, and not by ProtocolHRT;
  • no treatment, prescription or outcome is guaranteed;
  • you consent to synchronous and asynchronous care as described in Section 2;
  • the information you have given and will give is true, accurate and complete; and
  • you voluntarily consent to receive health care services from the Medical Group and its Providers through telehealth.

17.2 Electronic signature and copies. Your electronic acceptance is your signature and has the same effect as a handwritten signature under the federal Electronic Signatures in Global and National Commerce Act and applicable state law. You may download or print this Consent now, and you may request a copy of this Consent and each treatment-specific consent you accepted at any time through the patient portal. Clinical questions: ask your Provider through the patient portal or by calling ProtocolHRT support at 1-888-219-2204, which routes clinical questions to the Medical Group’s Providers. Billing and account questions: ProtocolHRT at support@protocolhrt.com or 1-888-219-2204.

17.3 Your acceptance. You accept this Consent in the patient portal by checking a separate box, not checked in advance, that reads: “I have read and agree to the Telehealth Informed Consent, including the compounded medication acknowledgment and the information about artificial intelligence, issued by LocumTele, the independent medical group whose Providers will evaluate me.”

Appendix A. State-Specific Disclosures

How this appendix applies. If you are located in one of the states below at the time of your visit, the disclosure for that state is part of this Consent.

Arizona. I understand that I am giving my informed consent to receive care through telehealth before any telehealth service is provided, and that I may give this consent in writing or electronically. If I give it verbally, my Provider will record it in my medical record.

California. Before I receive care through telehealth, the Medical Group has told me about the use of telehealth and has asked for my consent to telehealth as an acceptable way to receive health care. My consent is documented in my medical record. Agreeing to telehealth does not prevent me from receiving in-person care at any time during my treatment. My medical information is also protected by the California Confidentiality of Medical Information Act. If I receive a message about my health generated by artificial intelligence that was not reviewed by a licensed Provider, it will say so and will tell me how to reach a human Provider. No AI tool used in my care will be presented as a licensed health care professional.

Colorado. Beginning January 1, 2027, if automated decision technology is used in a way that materially influences a consequential decision about my health care, the Medical Group will tell me before it is used, explain any adverse decision and offer review by a person. The Medical Group does not use AI to decide whether I receive care.

Georgia. The Medical Group has given me the name and credentials of the Provider treating me and how to reach the Medical Group in an emergency: call 911 for any emergency, and for urgent concerns message my Provider through the patient portal. I have received instructions on what to do if I need emergency or follow-up care. While I am treated through telehealth, the Medical Group will make diligent efforts to have me seen and examined in person at least once a year, and I agree to cooperate with that effort or to tell the Medical Group about the in-person clinician who examines me.

Kentucky. Before my Provider prescribes any medication, the Medical Group will verify that I am who I say I am, my Provider will establish a documented diagnosis using accepted medical practices, and the Medical Group will keep a current medical record. My evaluation will not be based on a questionnaire alone, and my first evaluation will be a live video visit. I consent to receive telehealth services from the Medical Group.

Missouri. Any health questionnaire I complete is reviewed by my treating Provider as part of an evaluation, and my Provider will ask for more information or a live visit if needed. If I give the name of my primary health care provider, my Provider will send that provider a written report within fourteen (14) days of my evaluation stating my identity, the date of the evaluation, the diagnosis and treatment provided, if any, and any further instructions.

New Jersey. My telehealth visit may be with a health care provider who is not a physician. I may ask that my visit be scheduled with a physician, and if I do, it will be. The identity, professional credentials and contact information of my Provider are available to me before my visit, during it and for seventy-two (72) hours after it through the patient portal. If my Provider cares for me asynchronously, my Provider has reviewed my medical information beforehand and will tell me at the start of my care that my Provider has determined that the same standard of care as an in-person visit can be met. Before my evaluation, I received notice of the risks and benefits of being treated through telehealth (Sections 3 and 4 of this Consent) and of how to get follow-up care or help if I have an adverse reaction to treatment or if a technology or equipment failure prevents communication: for follow-up care or an adverse reaction, I will message my Provider through the patient portal, and in an emergency I will call 911 or go to the nearest emergency room; if a technology failure prevents communication, I will call 1-888-219-2204 and my message will be passed to the Medical Group. My dated electronic acceptance of this Consent is my signed and dated statement that I received this notice. Before my evaluation, I was also given the Medical Group’s Notice of Privacy Practices and asked to acknowledge receipt in writing.

Ohio. The Medical Group obtained my consent to telehealth, recorded in this Consent, before billing me for any telehealth service.

Texas. I give my informed consent before I receive any telemedicine or telehealth service. If I consent and have a primary care physician, or on my request, a medical record or report explaining the treatment provided and my Provider’s evaluation, analysis or diagnosis will be provided to my primary care physician within seventy-two (72) hours. The Medical Group discloses that artificial intelligence may be used in connection with my health care services or treatment as described in Section 8, and this disclosure is given to me before or on the date services are first provided. Where my Provider uses AI for diagnostic purposes, my Provider reviews all AI-generated records and tells me about that use.

Utah. Where a regulated health service involves a high-risk interaction with generative AI, I will be told at the start of a spoken interaction and before a written interaction that I am interacting with generative AI.